Bioelectronic cell-based device provides a strategy for the treatment of the experimental model of multiple sclerosis.

Publication Year: 2022

DOI:
10.1016/j.jconrel.2022.11.008

PMCID:
PMC9733677

PMID:
36370877

Journal Information

Full Title: J Control Release

Abbreviation: J Control Release

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability data will be made available on request. acknowledgement funding source: this project has received funding from the european union's horizon 2020 research and innovation program under grant agreement no 720694"

Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare no conflicts of interest."

Evidence found in paper:

"Funding source: This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No. 720694. Part of this work was carried out in the iVector Core facility, Histomics core facility, CELIS cell culture core facility and PHENOPARC core facility of ICM. We thank Clémence Tournaire for technical assistance."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025